Oregon Federal Court Says PharmacyChecker—Which Helps Americans Find Vetted International Online Pharmacies—Is Legal 

Last week, in Oregon’s Federal District Court, Judge Michael H. Simon denied summary judgment to the defendant, LegitScript, an online verification company, thwarting its effort to escape a lawsuit brought by PharmacyChecker. The antitrust lawsuit alleges that LegitScript illegally conspired with numerous Big Pharma-allied groups to blacklist PharmacyChecker on the Internet.  LegitScript argued that PharmacyChecker […]

Read More

Statements and Thoughts on Motion on Summary Judgment in PharmacyChecker v. NABP et al. 

[This post relates to a case titled PharmacyChecker.com v. the National Association of Boards of Pharmacy et al., in which PharmacyChecker alleges an unlawful “conspiracy involving front groups for Big Pharma” that keep “lower priced drugs out of reach of millions of Americans.” Just recently, a federal judge in New York’s southern district granted the defendants summary judgment.  This […]

Read More

Sen. Burr as Rip Van Winkle

Senator Burr: Rip Van Winkle Performance on Drug Importation, Owes Italy an Apology 

This past June, during a debate in the Senate Health, Education, Labor and Pensions (HELP) Committee,  Senator Richard Burr (R-NC), the committee’s Ranking Member, demonstrated that he does not understand very important developments in our nation’s approach to drug regulation and safety. It was almost as if Sen. Burr had fallen asleep over 20 years ago and woke […]

Read More

DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees

The U.S. Department of Justice, according to Seeking Alpha, is investigating the sale and distribution of counterfeit drugs in the U.S. that may have amounted to a quarter-billion dollars. The investigation comes about two months after The Wall Street Journal reported on a lawsuit filed by Gilead Sciences alleging a massive breach in the U.S. drug supply chain […]

Read More

Domain Reform for Unlawful Drug Sellers (DRUGS) Act (S. 3399)

The Domain Reform for Unlawful Drug Sellers Act is Big Pharma’s Bill

UPDATE: Senator Amy Klobuchar (D-MN) has withdrawn her sponsorship and support for this bill. A new bill introduced by Sens. Mark Rubio (R-FL) and Amy Klobuchar (D-MN), called the “Domain Reform for Unlawful Drug Sellers Act’’ or, for short, the ‘‘DRUGS Act,’’ could effectively end online access to safe and affordable imported medicines for Americans. […]

Read More